All In Biotech

Drug Trial Radar · NCT01226459

Clinical Trial in Females for Female Pattern Hair Loss

A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia)

Last checked: Nov 20, 2026Latest source record: Jun 10, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 404 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

404

Actual

Start

Sep 2010

Primary completion

Aug 2011

Study completion Aug 2011

Sponsor

Lead sponsor
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.Johnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
Collaborators
Johnson & Johnson Consumer and Personal Products Worldwide
First posted
Oct 22, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a six month clinical trial to evaluate the effectiveness and safety in women with Female Pattern Hair Loss (FPHL), comparing a 5% minoxidil topical foam (MTF) formulation applied once a day versus a topical foam vehicle (placebo) formulation applied once a day.

Conditions

  • Androgenetic Alopecia

Interventions

  • 5% Minoxidil Topical FoamDrug

    Dosage Form: 5% Minoxidil Topical Foam applied to the scalp; Dosage: half a cap, equivalent to 1 g of foam; Frequency: once every day; Duration: 24 weeks

  • Vehicle Topical FoamDrug

    Dosage Form: Vehicle Topical Foam applied to the scalp; Dosage: half a cap, equivalent to 1 g of foam; Frequency: once every day; Duration: 24 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target Area Hair CountTime frame: Baseline to Week 24
  2. Subject Assessment of Scalp CoverageTime frame: Week 24

Locations

17 sites in 4 countries. Site status is shown where the registry gives one.

  • Axis Clinical Trials

    Los Angeles, California

  • Axis Clinical Trials

    Los Angeles, California

  • Therapeutics Clinical Research

    San Diego, California

  • Heartland Research Associates LLC

    Wichita, Kansas

  • Callender Skin & Laser Center

    Glenn Dale, Maryland

  • Michigan Center for Skin Care Research

    Clinton Township, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • New York University School of Medicine

    New York, New York

  • Derm Research Center of New York

    Stony Brook, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • J&S Studies, Inc.

    College Station, Texas

  • David A. Whiting, MD PA

    Dallas, Texas

  • The Education & Research Foundation Inc

    Lynchburg, Virginia

  • Hôpital Saint Jacques Service de Dermatologie

    Besançon, France

  • Clinical Research Center for Hair and Skin Science Universitätsmedizin Berlin

    Berlin, Germany

  • Dermaticum Practice for Dermatology

    Freiburg im Breisgau, Germany

  • George Eliot Hospital

    Nuneaton, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.